Folic acid-conjugated MnO nanoparticles as a T1 contrast agent for Magnetic Resonance imaging of tiny brain gliomas

ACS Applied Materials and Interfaces

Volumn 6, Issue 22, 2014, Pages 19850-19857

  Chen, Ning ^a   Shao, Chen ^b   Qu, Yanming ^a   Li, Shuai ^b   Gu, Wei ^b   Zheng, Tingting ^b   Ye, Ling ^b   Yu, Chunjiang ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

Folic acid (fa); Magnetic resonance imaging (mri); Manganese oxide nanoparticles (mno nps); Tiny brain glioma

Indexed keywords

AMINES; BIOCOMPATIBILITY; DIAGNOSIS; ETHYLENE; IMAGE ENHANCEMENT; MAGNETIC RESONANCE IMAGING; MANGANESE REMOVAL (WATER TREATMENT); NANOMAGNETICS; NANOPARTICLES; OLEIC ACID; OXIDE MINERALS; RESONANCE; SILANES; TUMORS;

BRAIN GLIOMATA; CHEMICAL EQUATIONS; COLLOIDAL STABILITY; FOLIC ACIDS; MRI CONTRAST AGENTS; NANOPARTICLE (NPS); OXIDE NANOPARTICLES; WATER DISPERSIBLE;

MANGANESE OXIDE;

CONTRAST MEDIUM; FOLIC ACID; MANGANESE DERIVATIVE; MANGANESE OXIDE; NANOPARTICLE; OXIDE;

BRAIN; CHEMISTRY; DIAGNOSTIC USE; EARLY DIAGNOSIS; GLIOMA; HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; PROCEDURES; RADIOGRAPHY;

BRAIN; CONTRAST MEDIA; EARLY DETECTION OF CANCER; FOLIC ACID; GLIOMA; HUMANS; MAGNETIC RESONANCE IMAGING; MANGANESE COMPOUNDS; NANOPARTICLES; OXIDES;

EID: 84914693471     PISSN: 19448244     EISSN: 19448252     Source Type: Journal    
DOI: 10.1021/am505223t     Document Type: Article

References (35)

1. Wang, J.; Huang, Y.; David, A. E.; Chertok, B.; Zhang, L.; Yu, F.; Yang, V. C. Magnetic Nanoparticles for MRI of Brain Tumors. Curr. Pharm. Biotechnol. 2012, 13, 2403-2416.
2. Weissleder, R.; Pittet, M. J. Imaging in the Era of Molecular Oncology. Nature 2008, 452, 580-589.
3. Cao, Y.; Sundgren, P. C.; Tsien, C. I.; Chenevert, T. T.; Junck, L. Physiologic and Metabolic Magnetic Resonance Imaging in Gliomas. J. Clin. Oncol. 2006, 24, 1228-1235.
4. Pishko, G. L.; Astary, G. W.; Mareci, T. H.; Sarntinoranont, M. Sensitivity Analysis of an Image-based Solid Tumor Computational Model with Heterogeneous Vasculature and Porosity. Ann. Biomed. Eng. 2011, 39, 2360-2373.
5. Geninatti Crich, S.; Cabella, C.; Barge, A.; Belfiore, S.; Ghirelli, C.; Lattuada, L.; Lanzardo, S.; Mortillaro, A.; Tei, L.; Visigalli, M.; Forni, G.; Aime, S. In Vitro and In Vivo Magnetic Resonance Detection of Tumor Cells by Targeting Glutamine Transporters with Gd-based Probes. J. Med. Chem. 2006, 49, 4926-4936.
6. Luo, K.; Liu, G.; Zhang, X.; She, W.; He, B.; Nie, Y.; Li, L.; Wu, Y.; Zhang, Z.; Gong, Q. Functional L-Lysine Dendritic Macromolecules as Liver-Imaging Probes. Macromol. Biosci. 2009, 9, 1227-1236.
7. Zhou, Z.; Lu, Z. R. Gadolinium-based Contrast Agents for Magnetic Resonance Cancer Imaging. Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol. 2013, 5, 1-18.
8. Pan, D.; Schmieder, A. H.; Wickline, S. A.; Lanza, G. M. Manganese-based MRI Contrast Agents: Past, Present, and Future. Tetrahedron 2011, 67, 8431-8444.
9. Shin, J.; Anisur, R. M.; Ko, M. K.; Im, G. H.; Lee, J. H.; Lee, I. S. Hollow Manganese Oxide Nanoparticles as Multifunctional Agents for Magnetic Resonance Imaging and Drug Delivery. Angew. Chem., Int. Ed. 2009, 48, 321-324.
10. Huang, J.; Xie, J.; Chen, K.; Bu, L.; Lee, S.; Cheng, Z.; Li, X.; Chen, X. HSA Coated MnO Nanoparticles with Prominent MRI Contrast for Tumor Imaging. Chem. Commun. 2010, 46, 6684-6686.
11. Huang, C. C.; Khu, N. H.; Yeh, C. S. The Characteristics of Sub 10 nm Manganese Oxide T1 Contrast Agents of Different Nanostructured Morphologies. Biomaterials 2010, 31, 4073-4078.
12. Yang, H.; Zhuang, Y.; Hu, H.; Du, X.; Zhang, C.; Shi, X.; Wu, H.; Yang, S. Silica-Coated Manganese Oxide Nanoparticles as a Platform for Targeted Magnetic Resonance and Fluorescence Imaging of Cancer Cells. Adv. Funct. Mater. 2010, 20, 1733-1741.
13. Schladt, T. D.; Shukoor, M. I.; Schneider, K.; Tahir, M. N.; Natalio, F.; Ament, I.; Becker, J.; Jochum, F. D.; Weber, S.; Kohler, O.; Theato, P.; Schreiber, L. M.; Sonnichsen, C.; Schroder, H. C.; Muller, W. E.; Tremel, W. Au@MnO Nanoflowers: Hybrid Nanocomposites for Selective Dual Functionalization and Imaging. Angew. Chem., Int. Ed. 2010, 49, 3976-3980.
14. Kim, T.; Momin, E.; Choi, J.; Yuan, K.; Zaidi, H.; Kim, J.; Park, M.; Lee, N.; McMahon, M. T.; Quinones-Hinojosa, A.; Bulte, J. W. M.; Hyeon, T.; Gilad, A. A. Mesoporous Silica-Coated Hollow Manganese Oxide Nanoparticles as Positive T1 Contrast Agents for Labeling and MRI Tracking of Adipose-Derived Mesenchyrnal Stem Cells. J. Am. Chem. Soc. 2011, 133, 2955-2961.
15. Faucher, L.; Tremblay, M.; Lagueux, J.; Gossuin, Y.; Fortin, M.-A. Rapid Synthesis of PEGylated Ultrasmall Gadolinium Oxide Nanoparticles for Cell Labeling and Tracking with MRI. ACS Appl. Mater. Interfaces 2012, 4, 4506-4515.
16. Peer, D.; Karp, J. M.; Hong, S.; Farokhzad, O. C.; Margalit, R.; Langer, R. Nanocarriers as an Emerging Platform for Cancer Therapy. Nat. Nanotechnol. 2007, 2, 751-760.
17. 2-weighted Liver MRI. Biomaterials 2013, 34, 2069-2076.
18. Wankhede, M.; Bouras, A.; Kaluzova, M.; Hadjipanayis, C. G. Magnetic Nanoparticles: an Emerging Technology for Malignant Brain Tumor Imaging and Therapy. Expert Rev. Clin. Pharmacol. 2012, 5, 173-186.
19. Aina, O. H.; Sroka, T. C.; Chen, M. L.; Lam, K. S. Therapeutic Cancer Targeting Peptides. Biopolymers 2002, 66, 184-199.
20. Tomanek, B.; Iqbal, U.; Blasiak, B.; Abulrob, A.; Albaghdadi, H.; Matyas, J. R.; Ponjevic, D.; Sutherland, G. R. Evaluation of Brain Tumor Vessels Specific Contrast Agents for Glioblastoma Imaging. Neuro-oncology 2012, 14, 53-63.
21. Licciardi, M.; Scialabba, C.; Cavallaro, G.; Sangregorio, C.; Fantechi, E.; Giammona, G. Cell Uptake Enhancement of Folate Targeted Polymer Coated Magnetic Nanoparticles. J. Biomed. Nanotechnol. 2013, 9, 949-964.
22. Kang, C.; Yuan, X.; Li, F.; Pu, P.; Yu, S.; Shen, C.; Zhang, Z.; Zhang, Y. Evaluation of Folate-PAMAM for the Delivery of Antisense Oligonucleotides to Rat C6 Glioma Cells In Vitro and In Vivo. J. Biomed. Mater. Res., Part A 2010, 93, 585-594.
23. Weitman, S. D.; Frazier, K. M.; Kamen, B. A. The Folate Receptor in Central Nervous System Malignancies of Childhood. J. Neurooncol. 1994, 21, 107-112.
24. Zhao, X.; Li, H.; Lee, R. J. Targeted drug delivery via folate receptors. Expert Opin. Drug Delivery 2008, 5, 309-319.
25. Chauhan, R. P.; Mathur, R.; Singh, G.; Kaul, A.; Bag, N.; Singh, S.; Kumar, H.; Patra, M.; Mishra, A. K. Evaluation of Folate Conjugated Superparamagnetic Iron Oxide Nanoparticles for Scintigraphic/Magnetic Resonance Imaging. J. Biomed. Nanotechnol. 2013, 9, 323-334.
26. Lu, Y.; Low, P. S. Folate-mediated Delivery of Macromolecular Anticancer Therapeutic Agents. Adv. Drug Delivery Rev. 2002, 54, 675-693.
27. Bulte, J. W.; Kraitchman, D. L. Iron Oxide MR Contrast Agents for Molecular and Cellular Imaging. NMR Biomed. 2004, 17, 484-499.
28. 1 Contrast Agent for Magnetic Resonance Imaging using MnO Nanoparticles. Angew. Chem., Int. Ed. 2007, 119, 5497-5401.
29. Lee, J. H.; Huh, Y. M.; Jun, Y. W.; Seo, J. W.; Jang, J. T.; Song, H. T.; Kim, S.; Cho, E. J.; Yoon, H. G.; Suh, J. S.; Cheon, J. Artificially Engineered Magnetic Nanoparticles for Ultra-sensitive Molecular Imaging. Nat. Med. 2007, 13, 95-99.
30. Qi, Y.; Shao, C.; Gu, W.; Li, F.; Deng, Y.; Li, H.; Ye, L. Carboxylic Silane-exchanged Manganese Ferrite Nanoclusters with High Relaxivity for Magnetic Resonance Imaging. J. Mater. Chem. B 2013, 1, 1846-1851.
31. Xiao, J.; Tian, X. M.; Yang, C.; Liu, P.; Luo, N. Q.; Liang, Y.; Li, H. B.; Chen, D. H.; Wang, C. X.; Li, L.; Yang, G. W. Ultrahigh Relaxivity and Safe Probes of Manganese Oxide Nanoparticles for In Vivo Imaging. Sci. Rep. 2013, 3, 3424.
32. 1 Magnetic Resonance Imaging of Inflammatory Macrophages. Eur. J. Inorg. Chem. 2012, 5960-5965.
33. Li, X.; Shao, J.; Qin, Y.; Shao, C.; Zheng, T.; Ye, L. TAT-conjugated nanodiamond for the enhanced delivery of doxorubicin. J. Mater. Chem. 2011, 21, 7966-7973.
34. Hao, R.; Xing, R.; Xu, Z.; Hou, Y.; Gao, S.; Sun, S. Synthesis, Functionalization, and Biomedical Applications of Multifunctional Magnetic Nanoparticles. Adv. Mater. 2010, 22, 2729-2742.
35. Xie, H.; Zhu, Y.; Jiang, W.; Zhou, Q.; Yang, H.; Gu, N.; Zhang, Y.; Xu, H.; Xu, H.; Yang, X. Lactoferrin-conjugated Superparamagnetic Iron Oxide Nanoparticles as a Specific MRI Contrast Agent for Detection of Brain Glioma In Vivo. Biomaterials 2011, 32, 495-502.